This award funds highly creative scientists to pursue groundbreaking, high-risk research that could transform key areas of science related to the NIH mission.
This award funds creative early-stage researchers proposing innovative, high-impact projects in any NIH-relevant field, as part of NIH’s High-Risk, High-Reward Research Program.
Funds bold, unconventional research by individuals or teams aiming to transform science, clinical practices, or technology through high-risk, high-reward projects.
This award funds exceptional early-career researchers to launch independent NIH-relevant projects immediately after doctoral or clinical training, bypassing the typical postdoctoral phase.
NIH's R21 grant supports early-stage, high-risk clinical trial research with potential for breakthroughs in biomedical, behavioral, or clinical fields.
The National Institutes of Health supports investigator-initiated, multidisciplinary research programs organized around a shared scientific theme, with clinical trials optional.